Jialiang Huang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jialiang Huang has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Guilian Cheng
Department of Gastroenterology, Second Affiliated Hospital of Soochow University, Suzhou, China
3 shared publications Duanmin Hu
Department of Gastroenterology, Second Affiliated Hospital of Soochow University, Suzhou, China
2 shared publications- Duanmin Hu
Second Affiliated Hospital of Soochow University, Jiangsu, China
2 shared publications Guilian Cheng
Second Affiliated Hospital of Soochow University, Jiangsu, China
2 shared publicationsTianze Shi
Department of Gastroenterology, The Second Affiliated Hospital of Soochow University, Suzhou, China
2 shared publicationsBeinan Hu
Department of Gastroenterology, The Second Affiliated Hospital of Soochow University, Suzhou, China
1 shared publication
Latest Publications
- Open Access
- 1 October 2026
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 58 (S 05) , E1104-E1105
Endoscopic ultrasound-guided left gastric vein embolization: a novel minimally invasive approach for gastroesophageal varices-1
- 1 October 2026
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 58 (S 05) , E1104-E1105
Open AccessEndoscopic ultrasound-guided left gastric vein embolization: a novel minimally invasive approach for gastroesophageal varices-1
- Open Access
- 8 January 2026
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 58 (S 01) , E313-E315
Transesophageal endoscopic ultrasound-guided aspiration of the left atrium for diagnosis of T-cell lymphoblastic leukemia/lymphoma: a case report
A 20-year-old woman was admitted due to progressive chest tightness. Positron emission tomography/computed tomography (PET/CT) showed diffuse metabolic hyperactivity in the heart and local mediastinum, which was considered suspicious for malignancy ([Fig. 1]). To obtain a definitive pathological diagnosis, transesophageal endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) was planned. Examination of the mediastinum using a linear 7.5 MHz echoendoscope revealed the significant thickening of the left atrial wall ([Fig. 2]). Subsequently, the left atrium was punctured under EUS guidance using a 19G needle ([Fig. 3], [Video 1]). No postoperative complications were observed. EUS-FNA pathological examination with HE staining confirmed lymphoma, with the following immunophenotypic markers ([Fig. 4]): CD3 (positive), TdT (positive), and Ki-67 (positive, approximately 50% in hotspot areas). A final diagnosis of T-lymphoblastic leukemia/lymphoma(T-LBL/L) was established, providing a clear direction for subsequent treatments. Five months after chemotherapy, follow-up PET/CT showed significant improvement ([Fig. 5]). The patient remains under an ongoing follow-up. T-LBL/L is a highly aggressive malignancy derived from immature precursor T-cells, characterized by extensive infiltration of immature T-cells into the peripheral blood, bone marrow, and/or extramedullary organs, with the frequent involvement of the central nervous system [1] [2]. However, myocardial infiltration is extremely rare. This case demonstrates that EUS-FNA can successfully obtain tissue samples from left atrial lesions, leading to a definitive diagnosis of T-LBL/L and providing critical guidance for clinical management and prognosis. Therefore, the potential value of EUS in non-gastrointestinal pathologies should not be overlooked [3]. Although EUS is currently less commonly applied in non-digestive fields, it still holds significant clinical value. Such cross-disciplinary exploration and application can deepen our understanding of EUS and offer clinicians additional diagnostic and therapeutic insights. Endoscopy_UCTN_Code_TTT_1AS_2AC Article published online: 26 February 2026 © 2026. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/). Georg Thieme Verlag KG Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany
- 8 January 2026
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 58 (S 01) , E313-E315
Open AccessTransesophageal endoscopic ultrasound-guided aspiration of the left atrium for diagnosis of T-cell lymphoblastic leukemia/lymphoma: a case report
A 20-year-old woman was admitted due to progressive chest tightness. Positron emission tomography/computed tomography (PET/CT) showed diffuse metabolic hyperactivity in the heart and local mediastinum, which was considered suspicious for malignancy ([Fig. 1]). To obtain a definitive pathological diagnosis, transesophageal endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) was planned. Examination of the mediastinum using a linear 7.5 MHz echoendoscope revealed the significant thickening of the left atrial wall ([Fig. 2]). Subsequently, the left atrium was punctured under EUS guidance using a 19G needle ([Fig. 3], [Video 1]). No postoperative complications were observed. EUS-FNA pathological examination with HE staining confirmed lymphoma, with the following immunophenotypic markers ([Fig. 4]): CD3 (positive), TdT (positive), and Ki-67 (positive, approximately 50% in hotspot areas). A final diagnosis of T-lymphoblastic leukemia/lymphoma(T-LBL/L) was established, providing a clear direction for subsequent treatments. Five months after chemotherapy, follow-up PET/CT showed significant improvement ([Fig. 5]). The patient remains under an ongoing follow-up. T-LBL/L is a highly aggressive malignancy derived from immature precursor T-cells, characterized by extensive infiltration of immature T-cells into the peripheral blood, bone marrow, and/or extramedullary organs, with the frequent involvement of the central nervous system [1] [2]. However, myocardial infiltration is extremely rare. This case demonstrates that EUS-FNA can successfully obtain tissue samples from left atrial lesions, leading to a definitive diagnosis of T-LBL/L and providing critical guidance for clinical management and prognosis. Therefore, the potential value of EUS in non-gastrointestinal pathologies should not be overlooked [3]. Although EUS is currently less commonly applied in non-digestive fields, it still holds significant clinical value. Such cross-disciplinary exploration and application can deepen our understanding of EUS and offer clinicians additional diagnostic and therapeutic insights. Endoscopy_UCTN_Code_TTT_1AS_2AC Article published online: 26 February 2026 © 2026. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/). Georg Thieme Verlag KG Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany
- Open Access
- 8 January 2026
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 58 (S 01) , E250-E251
Rescue endoscopic ultrasound-guided hemostasis for massive gastric cancer bleeding after transcatheter arterial embolization
A 66-year-old man was admitted for massive gastrointestinal bleeding due to advanced gastric cancer with liver metastasis. He had undergone transcatheter artery embolization (TAE) of the left gastric artery for initial tumor hemorrhage 1 month prior ([Fig. 1]). Given the poor efficacy of conventional endoscopic therapy to diffuse tumor bleeding [1] and the patient refused surgery, emergency endoscopic ultrasound (EUS)-guided hemostasis was performed after careful communication with the patient and his family. Under general anesthesia with tracheal intubation, esophagogastroduodenoscopy (EGD) was first performed and revealed a huge tumor extending from the cardia to gastric body, with active bleeding point distributing across the tumor base ([Fig. 2]). A linear-array echoendoscope with color Doppler was then employed and observed multiple offending microvascular within submucosa. At the convergence point of these microvascular, a large vessel was identified as the dominant feeding vessel, providing major blood flow to the branches. Under EUS guidance, the feeding vessel was punctured with a standard 22-gauge needle. The intravascular location of the needle was confirmed by the injection of 0.5 mL of injection, followed by the administration of 1mL of cyanoacrylate, which resulted in the immediate disappearance of flow signals in the feeding vessel and its branches. Another large feeding vessel was identified at the gastric body and successfully embolized following the same procedure. After operation, repeat >EGD confirmed that no sustained bleeding occurred during 10-minute observation ([Fig. 3], [Video 1]). The patient was discharged on postoperative day 8 without adverse events or complications. No recurrent bleeding occurred within 1 month follow-up. EUS-guided hemostasis reported success rates of 78–100% in nonvariceal refractory bleeding [2] [3]. Han Chaoqun et al. reported a successful case of EUS-guided lauromacrogol injection for refractory gastric cancer bleeding[4]. To our knowledge, rescue EUS-guided hemostasis for massive gastric cancer recurrent bleeding after TAE have not been reported before. Endoscopy_UCTN_Code_TTT_1AS_2AB Article published online: 17 February 2026 © 2026. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/). Georg Thieme Verlag KG Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany
- 8 January 2026
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 58 (S 01) , E250-E251
Open AccessRescue endoscopic ultrasound-guided hemostasis for massive gastric cancer bleeding after transcatheter arterial embolization
A 66-year-old man was admitted for massive gastrointestinal bleeding due to advanced gastric cancer with liver metastasis. He had undergone transcatheter artery embolization (TAE) of the left gastric artery for initial tumor hemorrhage 1 month prior ([Fig. 1]). Given the poor efficacy of conventional endoscopic therapy to diffuse tumor bleeding [1] and the patient refused surgery, emergency endoscopic ultrasound (EUS)-guided hemostasis was performed after careful communication with the patient and his family. Under general anesthesia with tracheal intubation, esophagogastroduodenoscopy (EGD) was first performed and revealed a huge tumor extending from the cardia to gastric body, with active bleeding point distributing across the tumor base ([Fig. 2]). A linear-array echoendoscope with color Doppler was then employed and observed multiple offending microvascular within submucosa. At the convergence point of these microvascular, a large vessel was identified as the dominant feeding vessel, providing major blood flow to the branches. Under EUS guidance, the feeding vessel was punctured with a standard 22-gauge needle. The intravascular location of the needle was confirmed by the injection of 0.5 mL of injection, followed by the administration of 1mL of cyanoacrylate, which resulted in the immediate disappearance of flow signals in the feeding vessel and its branches. Another large feeding vessel was identified at the gastric body and successfully embolized following the same procedure. After operation, repeat >EGD confirmed that no sustained bleeding occurred during 10-minute observation ([Fig. 3], [Video 1]). The patient was discharged on postoperative day 8 without adverse events or complications. No recurrent bleeding occurred within 1 month follow-up. EUS-guided hemostasis reported success rates of 78–100% in nonvariceal refractory bleeding [2] [3]. Han Chaoqun et al. reported a successful case of EUS-guided lauromacrogol injection for refractory gastric cancer bleeding[4]. To our knowledge, rescue EUS-guided hemostasis for massive gastric cancer recurrent bleeding after TAE have not been reported before. Endoscopy_UCTN_Code_TTT_1AS_2AB Article published online: 17 February 2026 © 2026. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/). Georg Thieme Verlag KG Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany
- Open Access
- 30 November 2025
- Published by The Korean Society of Gastrointestinal Endoscopy in Clinical Endoscopy
- Vol. 58 (6) , 935-937
Exploratory application of endoscopic ultrasound-guided sclerotherapy in right renal cysts
Exploratory application of endoscopic ultrasound-guided sclerotherapy in right renal cysts
- 30 November 2025
- Published by The Korean Society of Gastrointestinal Endoscopy in Clinical Endoscopy
- Vol. 58 (6) , 935-937
Open AccessExploratory application of endoscopic ultrasound-guided sclerotherapy in right renal cysts
Exploratory application of endoscopic ultrasound-guided sclerotherapy in right renal cysts
- Open Access
- 14 January 2025
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 57 (S 01) , E1485-E1486
A case of cirrhosis with gastric varices and hypersplenism treated by endoscopic ultrasound-guided devascularization and partial splenic embolization (with video)
Variceal bleeding and hypersplenism are major complications of cirrhosis. While endoscopic N-butyl-2-cyanoacrylate injection and partial splenic embolization (PSE) are recommended [1], they entail risks of pulmonary embolism and splenic abscess. Recently, endoscopic ultrasound (EUS)-guided vascular intervention has emerged as an alternative [2]. In this case, we combined EUS-guided selective variceal devascularization (EUS-SVD) and EUS-guided PSE (EUS-PSE) to manage cirrhosis-induced gastric varices and hypersplenism. A 61-year-old man with alcoholic cirrhosis was referred to our hospital for recurrent melena. Despite previous transfusion, he was experiencing severe anemia due to hypersplenism. Endoscopy revealed esophagogastric varices and a venous aneurysm on the posterior gastric wall ([Fig. 1] a, b). Based on multidisciplinary assessment, we opted for EUS-SVD and EUS-PSE ([Video 1]). During the EUS-SVD procedure, the left gastric vein was identified and occluded using sequential sclerotherapy with lauromacrogol/tissue adhesive and an 8 × 12mm coil deployment ([Fig. 1] c). Successful thrombosis was confirmed, evidenced by a hyperechoic shadow and the absence of blood flow ([Fig. 1] d). After 1 month without rebleeding or adverse events, EUS-guided PSE was performed. Under EUS guidance, a primary splenic artery branch was identified and punctured with a 22G needle. An 8 mm × 12 mm coil was deployed, followed by lauromacrogol for tracing and 1 mL tissue adhesive for embolization ([Fig. 2] a). Subsequent imaging identified a lack of flow signal in the splenic artery and hyperechoic nodular in splenic parenchyma, indicating ischemia ([Fig. 2] b). Postoperatively, the patient experienced a transient fever of 38.6°C, managed with imipenem for 7 days. CT on day 4 confirmed over 50% splenic infarction and proper coil placement ([Fig. 2] c, d). The patient’s stool color normalized by discharge, without rebleeding or adverse events during 1-month follow-up. EUS-SVD demonstrates 95% clinical success with under 15% adverse events. No adverse events have been reported with EUS-PSE [3]. Herein, the combined therapy achieved success for cirrhosis-induced gastric varices and hypersplenism. Postoperative fever was attributed to sterile inflammation and absorption, which resolved in 3 days without CT evidence of splenic abscess. Endoscopy_UCTN_Code_TTT_1AS_2AG Article published online: 19 December 2025 © 2025. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/). Georg Thieme Verlag KG Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany
- 14 January 2025
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 57 (S 01) , E1485-E1486
Open AccessA case of cirrhosis with gastric varices and hypersplenism treated by endoscopic ultrasound-guided devascularization and partial splenic embolization (with video)
Variceal bleeding and hypersplenism are major complications of cirrhosis. While endoscopic N-butyl-2-cyanoacrylate injection and partial splenic embolization (PSE) are recommended [1], they entail risks of pulmonary embolism and splenic abscess. Recently, endoscopic ultrasound (EUS)-guided vascular intervention has emerged as an alternative [2]. In this case, we combined EUS-guided selective variceal devascularization (EUS-SVD) and EUS-guided PSE (EUS-PSE) to manage cirrhosis-induced gastric varices and hypersplenism. A 61-year-old man with alcoholic cirrhosis was referred to our hospital for recurrent melena. Despite previous transfusion, he was experiencing severe anemia due to hypersplenism. Endoscopy revealed esophagogastric varices and a venous aneurysm on the posterior gastric wall ([Fig. 1] a, b). Based on multidisciplinary assessment, we opted for EUS-SVD and EUS-PSE ([Video 1]). During the EUS-SVD procedure, the left gastric vein was identified and occluded using sequential sclerotherapy with lauromacrogol/tissue adhesive and an 8 × 12mm coil deployment ([Fig. 1] c). Successful thrombosis was confirmed, evidenced by a hyperechoic shadow and the absence of blood flow ([Fig. 1] d). After 1 month without rebleeding or adverse events, EUS-guided PSE was performed. Under EUS guidance, a primary splenic artery branch was identified and punctured with a 22G needle. An 8 mm × 12 mm coil was deployed, followed by lauromacrogol for tracing and 1 mL tissue adhesive for embolization ([Fig. 2] a). Subsequent imaging identified a lack of flow signal in the splenic artery and hyperechoic nodular in splenic parenchyma, indicating ischemia ([Fig. 2] b). Postoperatively, the patient experienced a transient fever of 38.6°C, managed with imipenem for 7 days. CT on day 4 confirmed over 50% splenic infarction and proper coil placement ([Fig. 2] c, d). The patient’s stool color normalized by discharge, without rebleeding or adverse events during 1-month follow-up. EUS-SVD demonstrates 95% clinical success with under 15% adverse events. No adverse events have been reported with EUS-PSE [3]. Herein, the combined therapy achieved success for cirrhosis-induced gastric varices and hypersplenism. Postoperative fever was attributed to sterile inflammation and absorption, which resolved in 3 days without CT evidence of splenic abscess. Endoscopy_UCTN_Code_TTT_1AS_2AG Article published online: 19 December 2025 © 2025. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/). Georg Thieme Verlag KG Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany